Status:
COMPLETED
Four Week Safety and Efficacy Study With a Topical Gel to Treat Common Warts in Pediatric Subjects
Lead Sponsor:
Graceway Pharmaceuticals, LLC
Conditions:
Warts
Eligibility:
All Genders
3-11 years
Phase:
PHASE2
Brief Summary
The primary purpose of this study is to evaluate the effectiveness in pediatric subjects of three different strengths of resiquimod gel applied to common wart(s) three times a week for four weeks. A ...
Eligibility Criteria
Inclusion
- Diagnosis of common warts
- Ages between 3 to 11
Exclusion
- Other types of wart(s), ie. plantar
- Currently participating in another clinical study
- Chronic viral hepatitis B or C
Key Trial Info
Start Date :
March 1 2005
Trial Type :
INTERVENTIONAL
End Date :
April 1 2006
Estimated Enrollment :
84 Patients enrolled
Trial Details
Trial ID
NCT00116675
Start Date
March 1 2005
End Date
April 1 2006
Last Update
February 19 2007
Active Locations (10)
Enter a location and click search to find clinical trials sorted by distance.
1
Children's Clinic of Jonesboro, PA
Jonesboro, Arkansas, United States, 72401
2
University of California - San Francisco
San Francisco, California, United States, 94143
3
Longmont Clinic/Longmont Medical Research Network
Longmont, Colorado, United States, 80501
4
Mercy Health Research
St Louis, Missouri, United States, 63141